EARLY Study

Study Type

Cognitive Impairment & Alzheimer's Disease

Study Purpose

The EARLY research study will test whether an investigational medication can slow down memory loss and prevent the development of Alzheimer’s disease in people who do not show signs of dementia.

About the Study

Scientists believe a buildup of protein in the brain (called "amyloid plaque deposits") may play a key role in the memory loss related to Alzheimer's disease. The EARLY research study will observe whether decreasing amyloid plaque deposits, through the use of an investigational medication, can help slow memory loss and prevent the development of Alzheimer's disease in people who do not show signs of dementia.

Study Design

Number of Visits:

  • 5 screening visits
  • 30 study visits

Procedures:

  • Physical and neurological examination
  • Vital signs and blood tests
  • Multiple questionnaires
  • Diagnostic tests such as MRI, PET Scan and ECG

Study Qualifications

To qualify for this research study, participants should:

  • Be 60 to 85 years old
  • Have normal thinking and memory abilities
  • Have a friend or family member willing to be your study partner (someone who has at least weekly contact with you and can answer questions once a year)

Study Duration

Participation in this study will last approximately five years.

Compensation

Study Contact

If you are interested in volunteering for the EARLY research study please call 225-763-2973 or e-mail dementia@pbrc.edu.

CALCULATE YOUR BMI

English Calculation
Enter Your Weight: 
 lbs.
Enter Your Height: 
 ft.  in.
Your BMI: